Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, an RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; WVE-007, a GalNAc-conjugated small interfering RNA designed to silence INHBE mRNA targeting obesity; WVE-N531, an exon skipping oligonucleotide for the treatment of Duchenne muscular dystrophy; and WVE-003, an allele-selective oligonucleotide for the treatment of Huntington's disease (HD). The company has collaboration agreements with GlaxoSmithKline for the research, development, and commercialization of oligonucleotide therapeutics; Takeda Pharmaceutical Company Limited for the research, development, and commercialization of oligonucleotide therapeutics for disorders of the Central Nervous System; and Asuragen, Inc. for the development and potential commercialization of companion diagnostics for investigational allele-selective therapeutic programs targeting HD. Wave Life Sciences Ltd. was incorporated in 2012 and is based in Singapore.

Wave Life Sciences Ltd.

Insiders have been trading these 5 stocks: (($BZUN)), (($PONY)), (($ADC)), (($SPRU)) and (($WVE)). Here is a breakdown of their recent trades and t...

Baozun, Pony AI, Agree Realty, Spruce, Wave Shock

In a report released today, Benjamin Burnett from Wells Fargo maintained a Buy rating on Wave Life Sciences, with a price target of $13.00. Accordi...

Wave Life Sciences (WVE) Receives a Buy from Wells Fargo

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Wave Life Sciences (WVE) and Kodiak Sciences (KOD) w...

Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE) and Kodiak Sciences (KOD)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Apogee Therapeutics (APGE – Research Report), Wave L...

Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE), Wave Life Sciences (WVE) and Telix Pharmaceuticals (OtherTLPPF)

Wave Life Sciences Pte. Ltd (($WVE)) has held its Q4 earnings call. Read on for the main highlights of the call. Wave Life Sciences’ latest earning...

Market Cap	$1.36B	P/E Ratio	N/A
52W High	$21.73	52W Low	$5.02
Div Yield	N/A	Payout Ratio	0.0%
EPS Growth 3Y	33.3%	52W Position	13.5%
Overall Score	36	Value Score	--
Quality Score	--	Technical Score	36

EPS Current Est	$-1.38	EPS Next Est	$-1.19
EPS Growth Est	N/A	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	WVE	$7.28	0.00%	4.07M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	WVE	$7.28	0%	4.07M
3
4
5
6

WVE

WVE

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Wave Life Sciences Ltd. Data in Excel

Get Wave Life Sciences Ltd. Data in Excel